USOR: Texas Oncology - The Woodlands, Gynecologic Oncology — The Woodlands, Texas

USOR: Texas Oncology - The Woodlands, Gynecologic Oncology is a clinical research site located in The Woodlands, Texas, United States 77380.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

USOR: Texas Oncology - The Woodlands, Gynecologic Oncology has participated in 2 clinical trials.

Therapeutic areas: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie, ImmunoGen, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in The Woodlands

Browse all research sites in Texas · View every site in The Woodlands

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USOR: Texas Oncology - The Woodlands, Gynecologic Oncology?

USOR: Texas Oncology - The Woodlands, Gynecologic Oncology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USOR: Texas Oncology - The Woodlands, Gynecologic Oncology conducted?

USOR: Texas Oncology - The Woodlands, Gynecologic Oncology has 2 clinical trials on record. Their work covers Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is USOR: Texas Oncology - The Woodlands, Gynecologic Oncology accredited by Crixeo Clinical Trials?

USOR: Texas Oncology - The Woodlands, Gynecologic Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USOR: Texas Oncology - The Woodlands, Gynecologic Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.